PDRX - PD-Rx Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
6.59
-0.16 (-2.37%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close6.75
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume639
Market Cap11.302M
Beta (3Y Monthly)1.11
PE Ratio (TTM)21.97
EPS (TTM)0.30
Earnings DateN/A
Forward Dividend & Yield1.32 (19.56%)
Ex-Dividend Date2018-12-13
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire4 days ago

    PD-Rx Declares Dividend

    OKLAHOMA CITY , Dec. 6, 2018 /PRNewswire/ -- The Board of Directors of PD-Rx Pharmaceuticals, Inc., a publicly held corporation, (OTC: PDRX) today announced that it has declared a onetime dividend of $2.20 ...

  • PR Newswire7 months ago

    PD-Rx Declares Dividend

    OKLAHOMA CITY, May 7, 2018 /PRNewswire/ -- The Board of Directors of PD-Rx Pharmaceuticals, Inc., a publicly held corporation, (PDRX) today announced that it has declared a one time dividend of $.66 per share payable on May 9, 2018 to shareholders of record at the close of business April 30, 2018.  This dividend represents a 9.8% projected annual yield utilizing the April 25, 2018 closing market price of $6.75. PD-Rx offers pharmaceutical and management strategies to the healthcare industry.  Our management strategies focus on new products, solid business partners, and the specialized segment of the pharmaceutical industry.  As a licensed FDA manufacturer and packager, PD-Rx offers a full spectrum of medications and specialized services.

  • We're sorry this is all we were able to find about this topic.